Two Indiana kids reportedly showing signs of heart disease
Walgreens says vaccine mix-ups are rare after Indiana families claimed their children were given coronavirus shots instead of flu shots.
family told WFIE In an exclusive interview that two of her children, ages 4 and 5, were accidentally given full adult doses of the Pfizer vaccine instead of flu shots at Walgreens in Evansville.
The mixing reportedly took place on October 4.
Due to privacy laws, Walgreens told Granthshala Business that it is not allowed to comment on specific patient incidents, but that patient safety is its “top priority” for the company and that it takes such matters very seriously.
“In general, such instances are rare, and Walgreens takes these matters very seriously,” Walgreens said in a statement. “In the event of any error, our first concern is always the well-being of our patients.”
Walgreens says it has a multi-step vaccination process that includes “multiple safety checks to reduce the potential for human error.” The company also noted that it has reviewed the multi-step vaccination process with its pharmacy staff as a means of preventing these events from occurring.
According to WFIE, the Price family didn’t know about the mix until a Walgreens employee admitted they made a mistake.
|anchor||the protection||The last||Change||Change %|
|wba||Walgreens Boots Alliance, Inc.||48.92||-1.85||-3.64%|
“Walgreens called me to say there was a mix, we didn’t get the flu shot,” said Alexandra Price.
After finding out that the kids were given a coronavirus shot instead, Price recalled thinking, “I was like, What does this mean for my kids…?”
David Tully, a lawyer for the Price family, told the outlet that the children were taken to the doctor and showed signs of heart disease.
Get Granthshala Business on the go by clicking here
Pfizer and BioNTech have not yet been approved for children’s vaccines. However, earlier this month, parents gave a signal of hope after companies asked the US government to authorize their COVID-19 vaccine for youths aged 5 to 11.
If regulators go ahead, a lower dose of the shot could be phased out in a matter of weeks. The companies said their research shows that young children should now get one-third of the dose given to everyone.